SOTGIU, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 8.790
EU - Europa 5.914
AS - Asia 2.749
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 28
SA - Sud America 18
AF - Africa 8
Totale 17.546
Nazione #
US - Stati Uniti d'America 8.735
UA - Ucraina 2.710
CN - Cina 2.599
DE - Germania 909
SE - Svezia 779
IT - Italia 691
FI - Finlandia 403
GB - Regno Unito 156
FR - Francia 89
TR - Turchia 51
CA - Canada 50
BE - Belgio 49
AU - Australia 37
IN - India 29
EU - Europa 27
IR - Iran 20
RO - Romania 17
ES - Italia 12
NL - Olanda 12
BR - Brasile 11
CH - Svizzera 8
HU - Ungheria 8
PL - Polonia 7
SG - Singapore 7
BG - Bulgaria 6
DK - Danimarca 6
MD - Moldavia 6
PT - Portogallo 6
SA - Arabia Saudita 6
EE - Estonia 5
JP - Giappone 5
AR - Argentina 4
AT - Austria 4
CZ - Repubblica Ceca 4
HK - Hong Kong 4
RU - Federazione Russa 4
AM - Armenia 3
BD - Bangladesh 3
HR - Croazia 3
ID - Indonesia 3
IE - Irlanda 3
LV - Lettonia 3
MX - Messico 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BF - Burkina Faso 2
EG - Egitto 2
IL - Israele 2
KR - Corea 2
ME - Montenegro 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
GE - Georgia 1
IQ - Iraq 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MK - Macedonia 1
NO - Norvegia 1
PH - Filippine 1
RS - Serbia 1
SI - Slovenia 1
SL - Sierra Leone 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
UZ - Uzbekistan 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 17.546
Città #
Chandler 2.045
Jacksonville 1.712
Princeton 892
Nanjing 813
Dearborn 637
Wilmington 358
Nanchang 282
Beijing 208
Ann Arbor 185
Boardman 183
Shenyang 183
Hebei 173
Tianjin 154
New York 148
Changsha 145
Jiaxing 114
Ashburn 104
Woodbridge 104
Jinan 94
Sassari 90
Andover 78
Kunming 78
Norwalk 64
Hangzhou 60
Ningbo 60
Zhengzhou 54
Brussels 48
San Francisco 48
Toronto 42
Milan 35
Taizhou 29
Guangzhou 27
Izmir 27
Haikou 24
San Mateo 23
Lanzhou 22
Rome 22
Leawood 21
Los Angeles 21
Mountain View 19
Auburn Hills 17
Monmouth Junction 16
Augusta 14
Edinburgh 14
Ardabil 13
Changchun 12
Melbourne 12
Sydney 12
Torino 12
Hefei 10
Frankfurt am Main 9
Helsinki 9
London 9
Seattle 9
Canberra 8
São Paulo 8
Washington 8
Amsterdam 7
Bari 7
Budapest 7
Fuzhou 7
Genoa 7
Hanover 7
Madrid 7
Bergamo 6
Bologna 6
Chisinau 6
Mumbai 6
Riyadh 6
Sofia 6
Trieste 6
Warsaw 6
Chicago 5
Cordovado 5
Oristano 5
Shaoxing 5
Tallinn 5
Tokyo 5
Copenhagen 4
Houston 4
Lurate Caccivio 4
Prague 4
Shanghai 4
Vienna 4
Almere Stad 3
Atlanta 3
Bacoli 3
Bellante 3
Brescia 3
Central 3
Chongqing 3
Delhi 3
Dublin 3
Florence 3
Mexico City 3
Montebelluna 3
Montreal 3
Naples 3
Padova 3
Palermo 3
Totale 9.817
Nome #
Sindrome di Morgagni-Stewart-Morel con crisi parziali: studio neuropsicologico e neuroradiologico di un caso 205
Dolore radicolare e potenziali evocati dermatomerici 149
GLI ANIMALI COLLABORATORI DELL’ATTIVITÀ INFERMIERISTICA IN OSPEDALE: SONDAGGIO DI OPINIONE IN UN REPARTO PEDIATRICO DEL NORD SARDEGNA 126
Rilevazione differenziale di MSRV e sincitina nel RNA e DNA di pazienti con sclerosi multipla 99
Cytoskeletal proteins in the cerebrospinal fluid as biomarker of multiple sclerosis. 87
Epidemiology of multiple sclerosis in the pediatric population of Sardinia, Italy 80
Immunological heterogeneity of multiple sclerosis in Sardinia and Sweden 79
Novel reliable real-time PCR for differential detection of MSRVenv and Syncytin-1 in RNA and DNA from patients with multiple sclerosis 73
P300 and executive function alterations: possible links in a case of Morgagni-Stewart-Morel syndrome 68
Genetic susceptibility to multiple sclerosis in Sardinians: an immunological study 66
Serum uric acid and multiple sclerosis 66
Optic neuritis and conversion to definite MS: comparison between MS-associated retrovirus and other prognostic markers 66
Potenziali evocati multimodali in pazienti affetti da distrofia miotonica 66
Genetic Epidemiology Of Multiple Sclerosis (MS) In Sardinia: Spatial Cluster Analysis. 66
Acquired hepatocerebral degeneration responsive to penicillamine: A case report 63
New virtual reality protocol for gait training in patients with multiple sclerosis 63
Multiple sclerosis distribution in northern Sardinia. Spatial cluster analysis of prevalence 61
Detection of Chlamydia Pneumoniae In the CSF of Sardinian Patients With Multiple Sclerosis In The Presence Or Absence Of Oligoclonal Bands 60
Trace elements in cerebrospinal fluid from patients with multiple sclerosis 60
Unequivocal linkage to multiple sclerosis of the MS-associated retrovirus in distinct European populations 60
Interaction of tonic labyrinth and neck reflexes in man. 60
Clinical expression of multiple sclerosis and the polymorphisms of the Chitotriosidase 60
Epidemiology and outcome of monosymptomatic optic neuritis in Northern Sardinia, Italy: a 12-year survey 59
A Proteomic Approach To Characterize A Native Antigen Involved In Autoantibody Response In Multiple Sclerosis By A Structure-Based Designed Glycopeptide 59
Anti-inflammatory nuclear receptor superfamily in multiple sclerosis patients from Sardinia and Sweden 59
Increasing incidence of multiple sclerosis in the province of Sassari, Sardinia 58
Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1 57
Extracellular release of the HERV-W Multiple sclerosis-associated retrovirus (MSRV) and its regulation by cytokines and HIV 57
Space-time clustering of multiple sclerosis in Northern Sardinia 57
“Hygiene hypothesis” and multiple sclerosis epidemiology in Sardinia 56
Risk For Multiple Sclerosis (MS) In Relatives Of Sardinian MS Patients. 56
A reappraisal of Multiple Sclerosis risk in Sardinians. 56
An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus 55
PREVALENCE OF CELIAC DISEASE IN NORTHERN SARDINIAN PATIENTS WITH MULTIPLE SCLEROSIS 55
Behavioral disturbances associated with hyperostosis frontalis interna: a neuroimaging study 55
Activating KIR molecules and their cognate ligands prevail in children with a diagnosis of ASD and in their mothers. 54
Multiple sclerosis: peripheral mononuclear cells inhibit Plasmodium falciparum growth and are activated by parasite antigens 54
Chitotriosidase in multiple sclerosis 54
Peripheral chitotriosidase in patients with multiple sclerosis 54
In vitro modulation of dendritic cells and lymphocytes by glatiramer acetate. Implications for multiple sclerosis treatment 54
A rare case of lupus-like syndrome during treatment with interferon β-1a. 54
Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk 54
Multiple sclerosis-associated retrovirus in patients with optic neuritis: prevalence and outccome in a Swedish cohort 54
Heavy metals and multiple sclerosis in Sardinian population (Italy). 54
Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis 54
The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis 54
A double-blind European Multicenter Study Evidences envelope protein from Human Endogenous Retrovirus W (MSRV-ENV or Syncytin) in serum from 73% of MS patients without selective clinical inclusion criteria 54
Evidence of early childhood as the susceptibility period in multiple sclerosis: space-time cluster analysis in a Sardinian population 53
Expression of human endogenous retroviruses in multiple sclerosis brain and glial cell cultures 53
Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis 53
Inflammatory biomarkers in blood of patients with acute brain ischemia 53
Self-perceived physical functioning and health status among fully ambulatory multiple sclerosis patients 53
Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis 53
Anti-alfa B-Crystallin T-cell lines in MS and healthy donors of Sardinian origin 52
Comparing multiple sclerosis (MS) frequency in two different italian provinces: evidence for a true risk rise in Sardinia 52
Profilo neurocognitivo in pazienti con Epilessia Focale Idiopatica a punte centro-temporali: confronto tra soggetti con evoluzione tipica e atipica 52
HLA-G coding region polymorphism is skewed in autistic spectrum disorders 52
Confirmation of a new phenotype in an individual with a variant in the last part of exon 30 of CREBBP 52
MSRV, Syncytin and the role of endogenous retroviral proteins in demyelination 51
Multiple sclerosis and hygiene hypothesis: reduced Toll-like receptor 9 expression in MS in response to P. falciparum 51
Incidence of pediatric Multiple Sclerosis in Sardinia, insular Italy (1968-2007) 51
Final Results of the Longitudinal Analysis of Autoimmunity Event Occurrence during Interferon Beta-1b (IFNb) Therapy 51
Cytochine regulation of the ERVWE1 promoter activity in astrocytic cells 51
A possible prognostic role for MSRV in multiple sclerosis. 51
Anti-Inflammatory Liver X Receptors and Related Molecules in Multiple Sclerosis Patients from Sardinia and Sweden 51
HLA Class II Haplotype In Sardinian Multiple Sclerosis: Suggestion For A Role Of Specific DRB And DQB Residues. 51
Multiple sclerosis and chitotriosidase: a novel association 51
Inheritance of Susceptible HLA-DRB-DQA-DQB Haplotypes In Sardinian Multiple Sclerosis 51
Epilepsy in definite multiple sclerosis (MS): comparison of two hospitalisation-based series in Sardinia 51
Le cellule Dendritiche nella Sclerosi Multipla. Supplemento n. 4, pp. 6-17. 51
Exploring by whole exome sequencing patients with initial diagnosis of Rubinstein–Taybi syndrome: the interconnections of epigenetic machinery disorders 51
HLA-DQB1 genotype in Sardinian multiple sclerosis: evidence for a key role of DQB1 *0201 and *0302 alleles 50
Glatiramer acetate reduces lymphocyte proliferation and enhances IL-5 and IL-13 production through modulation of monocyte-derived dendritic cells in multiple sclerosis 50
Sclerosi Multipla e Malaria 50
A new virtual reality protocol for gait training in patients with multiple sclerosis 50
Multiple sclerosis in twins from continental Italy and Sardinia: a nationwide study 50
Glatiramer acetate inhibits dendritic cells capability to stimulate lymphocytes proliferation 50
Multiple sclerosis-associated retrovirus and MS prognosis: an observational study 49
Epilepsy in multiple sclerosis: Does AED resistances predict a worse outcome of disability? 49
Multiple Sclerosis Distribution In The World: Evidence For A “Person-Related Disorder” 49
Il retrovirus HERV-W associato alla sclerosi multipla (MSRV) viene rilasciato da linfociti di soggetti portatori ed è sensibile a citochine e HIV 49
100% di positività per MSRV.( multiple sclerosis associated rerovirus) nel plasma di pazienti con sclerosi multipla di etnia Sarda 49
Intrathecal chitotriosidase and the outcome of multiple sclerosis 49
Multiple sclerosis in Sardinia 49
Absence seizures in childhood absence epilepsy and altered awareness in HIHARS: differential diagnosis 49
Acute flaccid paralysis surveillance in Sardinia during the period 1997-2015 49
Family-based transmission analysis of HLA genetic markers in Sardinian children with autistic spectrum disorders 49
Cytokines and multiple sclerosis severity: no correlation among Sardinians 49
Constitutive Expression of human endogenous retroviruses in normal and multiple sclerosis brains and glial cell cultures 49
Next generation sequencing in rare childhood epilepsy of suspected genetic etiology 49
Autoimmunity During Interferon Beta-1b (IFNb) Therapy For Multiple Sclerosis (MS) 49
Multiple sclerosis and multiple sclerosis-associated retrovirus in Sardinia. 48
Epidemiologia Genetica della Sclerosi Multipla Nella Provincia di Sassari. 48
La Chitotriosidasi nelle malattie neurologiche: focus sulla sclerosi multipla 48
Hepatitis B virus in Sardinian patients with multiple sclerosis: a seroprevalence study 48
Un caso clinico di Sindrome di FIRES con caratteristiche peculiari: analisi e considerazioni 48
Proteomic analysis of CSF in multiple sclerosis patients and controls: a study in Sardinian population 48
Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis. Case report. 48
A Case of Multiple Sclerosis and Hydrosyringomyelia: A Non-Coincidental Association? 48
Multiple Sclerosis Occurrence In RelativesoOf Sardinian Multiple Sclerosis Patients 48
Totale 5.829
Categoria #
all - tutte 72.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.103


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019431 0 0 0 0 0 0 0 0 0 0 11 420
2019/20204.568 1.203 11 402 17 430 573 827 45 483 106 460 11
2020/20213.523 439 8 612 22 435 183 439 3 549 530 215 88
2021/20221.860 271 11 6 12 5 3 98 155 173 61 211 854
2022/20234.277 458 136 46 682 472 741 17 551 794 53 219 108
2023/2024882 237 106 42 43 208 90 38 69 4 45 0 0
Totale 17.857